Great case highlighting utility of metanephrines with AVS in a patient with PA and hypercortisolism (MACS). Traditional AVS uses the aldo:cortisol ratio which is confounded if an adenoma co-secretes cortisol. tinyurl.com/yvhwpt75 @bhallaresearch.bsky.social
Always check 1mg DST in PA+adenoma!
Urine microalbumin getting Super Bowl star treatment with Sofia Vergara and Octavia Spencer.
Thus far, my impressions are: abbreviated; clunky; and pointless. 2/2
I would simply like to add my name to the chorus of folks who are struggling with this new NIH biosketch format. As both a grant writer to the NIH and a grant reviewer for the NIH, I have tried to see potential merits of this, but 1/2
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN.
med.stanford.edu/nephrology/e...
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN.
med.stanford.edu/nephrology/e...
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
x.com/stanford_htn...
Great reference
A famous nephrologist getting ready to go see the most famous guy who plays a nephrologist @glaucomflecken.bsky.social @stanforddeptmed.bsky.social Grand Rounds!
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl
#endocrinology @TheEndoSociety
Motherfucking wind farms…
Dr. Alessia Fornoni @alessiafornoni.bsky.social University of Miami describing her journey as a physician scientist, mentor, and drug developer- from a small town in northern Italy to her many roles today
Drs. Prabir Roy-Chaudry @asnkidney.bsky.social president of the ASN, @uncchapelhill.bsky.social as well as Drs. Rasheed Gbadegesin @dukepress.bsky.social and Emmanuel Opara @wakeforest.bsky.social kicking off the KUH R25 symposium @dknet.org at UNC chapel hill today
“There is a lot of pressure to essentially leave the country or not pursue research.” scim.ag/3Gz4VWW
Presented at the #ADASciSessions:
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. This phase 1–2 study supports the hypothesis that zimislecel can restore physiologic islet function and thus treat persons with type 1 diabetes. Full study results: nej.md/3ZGupbv
Congratulations to the #StanDOM recipients of the 2025 Stanford Medicine Awards, who were recognized for their outstanding contributions to medical education & leadership during the June 14 @stanfordmedicine.bsky.social graduation.
Atul Butte died yesterday.
The world lost a giant.
A big bear of a man.
With a huge smile.
With love for everyone.
With energy that could power a room.
I loved everything about Atul.
I loved how he was always happy.
I loved how excited he was about science and helping people.
I don't care if these monstrous ICE raids are a "federal operation". This is authoritarian violence, plain and simple.
award winner list
Congrats to all the @asnkidney.bsky.social lifetime and mid-career awardees!
@ksusztak.bsky.social @genetickidneydoc.bsky.social @shinamenon.bsky.social @michellejtx.bsky.social and everyone else!
Congratulations to all who advocated and thank you to all those who supported!!
🎉🎉🎉🎉🎉
@WHO.int
@ISN.org
#Guatamala
@CharuMalik.bsky.social
Ifeoma Ulasi
Magda Machalska
@UKKidney.org
@kidneycareuk.org
@KidneyResearch.org
#kidneyhealthforall
#WHA78
The Dutch are responsible for many wonderful things, but are any as great as the stroopwafel and coffee combo? 🇳🇱☕️🧇
Zosia is very jealous
Wanpen- interesting …do you have a reference? I believe baxdrostat is via CYP3A4? (Ie similar to eplerenone and tacrolimus, and therefore concerns with things like diltiazem and paxlovid)
A graph showing the least-squares mean changes from baseline (randomization) in the 24-hour average ambulatory systolic blood pressure at 12 weeks.
In the Advance-HTN phase 2b trial of the aldosterone synthase inhibitor lorundrostat in participants with uncontrolled hypertension, lorundrostat was associated with greater reductions in blood pressure than placebo. Full trial results: nej.md/4ipbCIf
#MedSky #CardioSky
Amen!
Kidney disease should be recognised on WHO's priority list of non-communicable diseases, alongside cancer, cardiovascular disease, and diabetes
https://go.nature.com/4lLJ5iY
but this could change soon with ARCTIC, PACIFIC trials
Full disclosure: SABs for AZ, Bayer
aldosterone sensitivity, etc.
Regarding ASIs vs MRAs, I was a big believer in eplerenone with its fewer side effects but have accumulated more and more folks where it’s simply not potent enough. This creates a lane for ASIs. nsMRAs (possibly MRAs in general) still have the upper hand for GDMT 2/n
Very exciting news…..success with this broad cohort continues a slow and steady march for blockade of aldosterone signaling as a major tool in hypertension more broadly (not just obvious cases of PA) by likely capturing common cases of subclinical PA, aldosterone dysregulation, 1/n
